Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with semaglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results